Business Insights

In this episode, our partners Thilo Kaltenbach and Karsten Neumann explore the rapidly evolving landscape of AI in healthcare. It is pretty clear that AI is transforming our lives and all industries. However, how does it play out in the highly regulated healthcare market? Is it more revolution or evolution? From early diagnosis to personalized medicine, AI-powered hospitals and workforce changes, the topic highlights the tangible impacts of AI on patients, physicians, and organizations. With executives aware of AI's potential but facing readiness gaps, key strategic moves need to be executed to stay ahead in this fast-moving field.
For more...

In this episode, biologist, TV anchor, and staYoung founder Nina Ruge joins our partner Thilo Kaltenbach to explore the increasing focus on life expectancy and health span. Both have risen significantly over the past century, and new medicines and nutritional supplements are now shaping the next phase of the market for healthy aging.
As aging affects everyone, the longevity sector is creating new opportunities for pharma companies, healthcare providers, and investors. With the market expected to double to $60 billion by 2033, early investments in innovation could deliver strong returns.
For more information, visit our website at rolandberger.com.

In this episode, our experts Thilo Kaltenbach and Marina Gilic discuss the growing importance of Environmental, Social, and Governance (ESG) in the MedTech industry. As regulations evolve and customer expectations shift, companies must meet increasing demands for sustainability, patient access, and governance compliance.
Beyond meeting requirements, ESG also presents a significant business opportunity. MedTech companies that embrace ESG can strengthen their positioning as problem solvers, service leaders, and innovators in their field. How can businesses navigate these challenges and develop responsible strategies?
For more information, visit our website at rolandberger.com.

In the first episode of our Business Insights series on Health topics, our experts Thilo Kaltenbach and Stephan Fath explore the critical issue of drug availability and the challenges facing pharmaceutical supply chains. Rising global demand, geopolitical tensions, and evolving regulations have created significant disruptions, particularly for essential medicines.
Our experts discuss how pharmaceutical companies and governments are responding to these challenges. They highlight strategies such as localizing production, improving supply chain resilience, and leveraging new technologies. What role will AI and modular manufacturing play in securing future pharmaceutical supply? And how will companies navigate the complexities of regional supply...